Advances of the Nanotechnology in Targeted Nanomedicines for Treatment of Bone Cancers and Diseases
- Authors
-
-
Fabio Franceschini Mitri
Department of Human Anatomy, Institute of Biomedical Sciences, Federal University of Uberlandia, Uberlandia/MG, Brazil
-
- Keywords:
- Nanotechnology, Nanomedicine, Nanodrugs, Bone Cancer, Osteosarcoma, Bone Infection, Osteoarthritis, Targeted Delivery.
- Abstract
-
The ever-evolving field of nanotechnology has been applied over the years as an amazing potential tool in bone disorders through the development of targeted drug nanosystems. Bone diseases can be referred as any bone condition able to cause morbidity or even mortality to the host. Osteosarcoma has been most investigated condition for management and treatment by nanomedicine, and several nanomaterials such as nanoparticles, nanocapsules, nanospheres, nanodiamonds are being used for drug delivery. Likewise, other bone diseases, such as osteoporosis, osteonecrosis, osteoarthritis, bone tuberculosis have received nanotherapy with a large rate of success. The nanomedicine seems to make up a targeting lack by conventional therapy and chemotherapy, besides appointing to a trend of conservative clinical treatment, especially for severe disorders. Additionally, nanomedicine has advanced over the years, therefore, there is a strong need to accelerate its application in bone diseases reducing the mortality rate related to these conditions. This review article provides an overview on the advances of nanotechnology over the last two decades and highlights the pathways of investigations for targeted delivery nanoensembles.
- Downloads
-
Download data is not yet available.
- Downloads
- Published
- 30-12-2021
- Issue
- Vol. 10 (2021)
- Section
- Articles
How to Cite
Similar Articles
- Teoh Han Pinn, Siti Fathiah Masre, Nadiah Abu, MiR-130b-3p Suppress the Migration, Proliferation and Chemosensitization of Hepatocellular Carcinoma Cells , Journal of Cancer Research Updates: Vol. 13 (2024)
- Chao-Zhan Lin, Ai-Zhi Wu, Ying Zhong, Yu-Mei Wang, Guang-Tian Peng, Xian-Jun Su, Bing-Xin Liu, Yun Deng, Chen-Chen Zhu, Cui-Xian Zhang, Flavonoids from Psychotria serpens L., a Herbal Medicine with Anti-Cancer Activity , Journal of Cancer Research Updates: Vol. 4 No. 2 (2015): Special Issue - Natural Products for Cancer Prevention and Treatment
- Víctor Juan Vera-Ponce, Fiorella E. Zuzunaga-Montoya, Nataly Mayely Sanchez-Tamay, Lupita Ana Maria Valladolid-Sandoval, Jhosmer Ballena-Caicedo, Juan Carlos Bustamante-Rodríguez, Angie Chuquimbalqui Coronel, Christian Humberto Huaman-Vega, Carmen Inés Gutierrez De Carrillo, Obesity as a Risk Factor and Prognostic Indicator for B-cell Lymphoma: An Umbrella Review , Journal of Cancer Research Updates: Vol. 14 (2025)
- Irene Ruiz, Freddy Fernando Durán, Carmen Sáez, Julián Sanz, Adela Pelayo, Fernando Moreno, Jorge Ruiz, Luis Ortega, Alejandro Pascual, HER2 Expression Discordance between Ductal Carcinoma In situ and Invasive Breast Carcinoma. How to Analyze Oncotype DX , Journal of Cancer Research Updates: Vol. 8 No. 1 (2019)
- S.K. Gantsev , S.R. Kzyrgalin, K.S. Gantsev, Peritumoral Lymphangiogenesis in Breast Carcinoma , Journal of Cancer Research Updates: Vol. 9 No. 1 (2020)
- Bibo Wang, Yiping Han, Jiajie Zang, Expression of p63 in Squamous Cell Carcinoma of the Lung and its Diagnostic Significance: A Meta-Analysis , Journal of Cancer Research Updates: Vol. 1 No. 2 (2012)
- You-Qiu Xue, Ke-Jun Cheng, Jian-Ge Qiu, Xiao-Long Mei, Wen-Ji Zhang, Qi-Wei Jiang, Wu-Ming Qin, Yang Yang, Di-Wei Zheng, Yao Chen, Meng-Ning Wei, Dong-Mei Huo, Xing Wei, Zhi Shi, Antioxidant and Anticancer Activities of Raspberry Extracts , Journal of Cancer Research Updates: Vol. 4 No. 2 (2015): Special Issue - Natural Products for Cancer Prevention and Treatment
- Aeshah Muhana Mohammed, Jameelah Kadhim Taher Al-Isawi, Muqdad Khamis Abd, De Novo Design and Molecular Dynamics Evaluation of AZ67-Derived Allosteric PFKFB3 Modulators for Anticancer Metabolic Drug Discovery , Journal of Cancer Research Updates: Vol. 15 No. 3 (2026)
- W.M.M.S. Bandara, F.T. Muhinudeen, S.L. Malaviarachchi, A.J.I.S. Rathnayake, Potential of Pre-Operative Serum Interleukin-6 as a Biomarker for Colorectal Cancers , Journal of Cancer Research Updates: Vol. 13 (2024)
- Ananda M. Chakrabarty, COMMENTARY: BRCA1/2 Mutations, Vulnerability to Breast/Ovarian Cancer, and Current and Future Treatment Modalities , Journal of Cancer Research Updates: Vol. 5 No. 2 (2016)
You may also start an advanced similarity search for this article.